Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q2 2026 (June 30)5holders −1
0new positions
1sold out
$8.87avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($87K), PNC Financial Services Group, Inc. ($48K) and Westside Investment Management, Inc. ($20K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $33K |
All 13F filers, Q1 2026 → Q2 2026: 1,926 shares bought and 3,901 shares sold, net −1,975 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Rhumbline Advisers | 0.00% | Add +1.5% | 9,788 | $87K |
| PNC Financial Services Group, Inc. | 0.00% | Add +36.5% | 5,383 | $48K |
| Westside Investment Management, Inc. | 0.00% | No change | 2,229 | $20K |
| GAMMA Investing LLC | 0.00% | Add +20.2% | 1,919 | $17K |
| IMA Advisory Services, Inc. | 0.00% | Add +83.3% | 44 | $390 |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.